Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2022 Earnings

10FebConfirmed

Q2 2021

Q3 2021

Q4 2021

Q1 2022

-11.34

-10.15

-8.96

-7.77

Details

Expected EPS

-7.7679279999999995

Actual EPS

-11.336976

Surprise EPS

-3.57

Surprise Percent

+45.95%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -11.336976 per share for Q1 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.